Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1982; Volume 21,Issue 3
  • You have access
    beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
    W H Bulger and D Kupfer
    Molecular Pharmacology May 1982, 21 (3) 533-537;
  • You have access
    Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.
    R B Rothman and T C Westfall
    Molecular Pharmacology May 1982, 21 (3) 538-547;
  • You have access
    Allosteric coupling between morphine and enkephalin receptors in vitro.
    R B Rothman and T C Westfall
    Molecular Pharmacology May 1982, 21 (3) 548-557;
  • You have access
    Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
    Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
    Molecular Pharmacology May 1982, 21 (3) 558-563;
  • You have access
    The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
    Y Kouakou, J M Zajac, C Moisand and J C Meunier
    Molecular Pharmacology May 1982, 21 (3) 564-569;
  • You have access
    Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
    T K Harden, A G Scheer and M M Smith
    Molecular Pharmacology May 1982, 21 (3) 570-580;
  • You have access
    Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
    M Waelbroeck, P Robberecht, P Chatelain and J Christophe
    Molecular Pharmacology May 1982, 21 (3) 581-588;
  • You have access
    Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
    P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
    Molecular Pharmacology May 1982, 21 (3) 589-593;
  • You have access
    Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
    B Ringdahl, F J Ehler and D J Jenden
    Molecular Pharmacology May 1982, 21 (3) 594-599;
  • You have access
    Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
    Molecular Pharmacology May 1982, 21 (3) 600-608;
  • You have access
    Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
    L E Limbird, J L Speck and S K Smith
    Molecular Pharmacology May 1982, 21 (3) 609-617;
  • You have access
    Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding.
    J D Hirsch, R L Kochman and P R Sumner
    Molecular Pharmacology May 1982, 21 (3) 618-628;
  • You have access
    Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
    M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
    Molecular Pharmacology May 1982, 21 (3) 629-636;
  • You have access
    Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
    L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
    Molecular Pharmacology May 1982, 21 (3) 637-647;
  • You have access
    Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
    S Yamazaki, T Katada and M Ui
    Molecular Pharmacology May 1982, 21 (3) 648-653;
  • You have access
    The relationship between the carbachol stimulatory effect on cyclic GMP content and activation by fatty acid hydroperoxides of a soluble guanylate cyclase in the guinea pig myometrium.
    D Leiber and S Harbon
    Molecular Pharmacology May 1982, 21 (3) 654-663;
  • You have access
    Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites.
    A C Howlett
    Molecular Pharmacology May 1982, 21 (3) 664-670;
  • You have access
    Histamine-mediated adenylate cyclase stimulation in human myocardium.
    M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
    Molecular Pharmacology May 1982, 21 (3) 671-679;
  • You have access
    Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
    A M Siegl, J W Daly and J B Smith
    Molecular Pharmacology May 1982, 21 (3) 680-687;
  • You have access
    The formation of diarachidonyl diglyceride by rat neutrophils.
    M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
    Molecular Pharmacology May 1982, 21 (3) 688-693;
  • You have access
    Movement of free cholesterol from lipoproteins or lipid vesicles into erythrocytes. Acceleration by ethanol in vitro.
    C K Daniels and D B Goldstein
    Molecular Pharmacology May 1982, 21 (3) 694-700;
  • You have access
    1H Fourier transform nuclear magnetic resonance relaxation rate studies on the interaction of acetanilide with purified isozymes of rabbit liver microsomal cytochrome P-450 and with cytochrome b5.
    R F Novak and K P Vatsis
    Molecular Pharmacology May 1982, 21 (3) 701-709;
  • You have access
    Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
    J R Trudell, B Bösterling and A J Trevor
    Molecular Pharmacology May 1982, 21 (3) 710-717;
  • You have access
    Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
    D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
    Molecular Pharmacology May 1982, 21 (3) 718-722;
  • You have access
    Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
    W L Washtien
    Molecular Pharmacology May 1982, 21 (3) 723-728;
  • You have access
    Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
    K D Tew and A L Wang
    Molecular Pharmacology May 1982, 21 (3) 729-738;
  • You have access
    Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
    S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
    Molecular Pharmacology May 1982, 21 (3) 739-743;
  • You have access
    Neonatal imprinting and hepatic cytochrome P-450. Immunochemical evidence for the presence of a sex-dependent and neonatally imprinted form(s) of hepatic cytochrome P-450.
    H Chao and L W Chung
    Molecular Pharmacology May 1982, 21 (3) 744-752;
  • You have access
    Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
    D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
    Molecular Pharmacology May 1982, 21 (3) 753-760;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 21, Issue 3
1 May 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics